Phathom Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Phathom Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker PHAT.
Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada....
Can you invest in Phathom Pharmaceuticals, Inc.?
Yes. Phathom Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker PHAT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Phathom Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.